StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$390.30−6.39 (-1.61%)

Close on Nov 20, 2026Market cap $27.19BP/E 43.8Yield 0.22%

West Pharmaceutical Services Stock-Based Compensation by Quarter

Stock-Based Compensation ($M)

West Pharmaceutical Services Stock-Based Compensation: $4.30M in Q3 2026, down 48.8% from a year earlier.

Latest, Q3 2026
4.30
Period ended Sep 30, 2026
Change on a year earlier
-48.8%
8.40 in Q3 2025
History
63 quarters
Since Q1 2011
Sources
58
Documents cited below

Where the Q3 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: West Form 10-Q (filed 2026-10-29) ↗

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedStock-Based Compensation ($M)Year on yearSource
Q3 2026Sep 30, 20264.30-48.8%West Form 10-Q (filed 2026-10-29) ↗
Q2 2026Jun 30, 202610.9+47.3%West Form 10-Q (filed 2026-07-23) ↗
Q1 2026Mar 31, 20266.60+407.7%West Form 10-Q (filed 2026-04-23) ↗
Q4 2025Dec 31, 20256.70+55.8%West Form 10-K (filed 2026-02-17) ↗
Q3 2025Sep 30, 20258.40+64.7%West Form 10-Q (filed 2025-10-23) ↗
Q2 2025Jun 30, 20257.40+72.1%West Form 10-Q (filed 2025-07-24) ↗
Q1 2025Mar 31, 20251.30-74.0%West Form 10-Q (filed 2025-04-24) ↗
Q4 2024Dec 31, 20244.30+207.1%West Form 10-K (filed 2025-02-18) ↗
Q3 2024Sep 30, 20245.10-13.6%West Form 10-Q (filed 2024-10-24) ↗
Q2 2024Jun 30, 20244.30-42.7%West Form 10-Q (filed 2024-07-25) ↗
Q1 2024Mar 31, 20245-41.2%West Form 10-Q (filed 2024-04-25) ↗
Q4 2023Dec 31, 20231.40-79.1%West Form 10-K (filed 2024-02-20) ↗
Q3 2023Sep 30, 20235.90-1.7%West Form 10-Q (filed 2023-10-26) ↗
Q2 2023Jun 30, 20237.50+36.4%West Form 10-Q (filed 2023-07-27) ↗
Q1 2023Mar 31, 20238.50+54.5%West Form 10-Q (filed 2023-04-27) ↗
Q4 2022Dec 31, 20226.70-33.0%West Form 10-K (filed 2023-02-21) ↗

Cite this data

StockData. (2026). West Pharmaceutical Services Stock-Based Compensation ($M), quarterly Q1 2011–Q3 2026 [Data set]. Compiled from West Pharmaceutical Services SEC filings and investor materials. https://stockdatahq.com/stocks/wst/kpis/db-cf-sbc

See every metric in the West Pharmaceutical Services KPI table. Data updated Nov 9, 2026.

See a number that looks wrong?